How does neuroblastoma begin and can we use this knowledge to develop new treatments?
Dissecting the role of MYCN in neuroblastoma initiation
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Dissecting the role of MYCN in neuroblastoma initiation
Towards a new therapy against childhood brain cancer: How does the Zika virus kill aggressive brain tumour cells?
Optimising tyrosine kinase inhibitor therapy in newly diagnosed metastatic Ewing sarcoma
MG-fnRMS and CINSARC gene expression signatures to predict relapse in fusion gene negative rhabdomyosarcomas: assessing an approach to improve patient outcomes
An open label, single centre, single arm, prospective feasibility study evaluating the effectiveness of near-infrared fluorescence(NIRF)using indo-cyanine green(ICG)in intra-abdominal or intra-thoracic minimally invasive surgery(MIS)in paediatric oncology.
Deciphering the genomic landscape of childhood refractory t-cell acute lymphoblastic leukaemia
Investigating repurposed drugs to decrease the progression of Ewing’s sarcoma
Living with treatment-related hearing loss: Experiences of survivors of childhood brain cancer
What helps and what hinders in remotely delivered acceptance and commitment therapy for survivors of childhood brain tumours: a diary and interview study.